Governance
The Human Cell Atlas comprises members from many scientific institutions around the world. It is only by working together that we will be able to achieve the ambitious goals of this project.
The HCA is steered and governed by an Organizing Committee (OC), which is the decision-making body of the HCA. The OC is co-chaired by Aviv Regev and Sarah Teichmann. Muzz Haniffa and Chloe Villani serve as vice-chairs, and Shyam Prabhakar serves as Global Coordination Lead.
Members of the HCA Advisory Committee (AC) provide guidance and insight to the HCA Organizing Committee, and may attend OC meetings as observers.
The OC has an Executive Committee (EC) that is responsible for performing routine tasks between OC meetings, reviewing meeting agendas, and providing guidance to the HCA Executive Office.
Committee Members
University of Buenos Aires, Argentina
University of Toronto, Canada
CeMM, Austria
Fondazione Human Technopole, Italy & RIKEN, Japan
Berlin Institute of Health – Charité Universitätsmedizin Berlin, Germany
Wellcome Sanger Institute/Newcastle University, UK
Stanford University, USA
University of California, San Francisco, USA
Allen Institute, USA
Karolinska Institutet, Sweden
John C. Martin Centre for Liver Research & Innovations and Liver Foundation, West Bengal, India
Radboud University, The Netherlands
Stanford University, USA
Memorial Sloan Kettering Cancer Institute, USA
Genome Institute of Singapore, Singapore
Genentech, USA
Albert Einstein Research and Education Institute, Brazil
Genomic Institute of Singapore, A*STAR, Singapore
Cambridge Stem Cell Institute & Dept Medicine, Cambridge University
Helmholtz-Munich, Germany
Massachusetts General Hospital, Harvard Medical School and Broad Institute, USA
University of Melbourne, Australia
Alumni (OC)
Wellcome Sanger Institute, UK
Hubrecht Institute, The Netherlands
Broad Institute, USA
Edinburgh University, UK
Stanford University / CZ Biohub, USA
Weizmann Institute, Israel
Wellcome Sanger Institute, UK
Organising Committee (OC)
Broad Institute, USA
Genentech, USA; EMBL-EBI, Cambridge, UK
Mount Sinai, USA
Helmholtz Association, Germany
Prinses Maxima Centrum, The Netherlands
Massachusetts Institute of Technology, USA
Howard Hughes Medical Institute, USA and Harvard University, USA
Hubrecht Institute, The Netherlands
Advisory Committee (AC)
University of Toronto, Canada
Fondazione Human Technopole, Italy & RIKEN, Japan
Wellcome Sanger Institute/Newcastle University, UK
Genome Institute of Singapore, Singapore
Genentech, USA
Cambridge Stem Cell Institute & Dept Medicine, Cambridge University
Massachusetts General Hospital, Harvard Medical School and Broad Institute, USA